AI assistant
Saudi Chemical Co. — Earnings Release 2019
Mar 26, 2020
53314_rns_2020-03-26_c331cc8e-d5ed-4c2b-9837-19b773173b8a.html
Earnings Release
Open in viewerOpens in your device viewer
Saudi Chemical Co. announces its Annual Financial Results for the Period Ending on 2019-12-31
2230 · 26/03/2020 08:17:32 · Announcement #58106 · View on Saudi Exchange
Saudi Chemical Co. announces its Annual Financial Results for the Period Ending on 2019-12-31
| Element List | Current Year | Previous Year | %Change |
|---|---|---|---|
| Sales/Revenue | 2,949,168 | 2,948,532 | 0.021 |
| Gross Profit (Loss) | 457,962 | 428,544 | 6.864 |
| Operational Profit (Loss) | 124,487 | 183,935 | -32.32 |
| Net Profit (Loss) after Zakat and Tax | 32,877 | 114,824 | -71.367 |
| Total Comprehensive Income | 31,441 | 118,107 | -73.379 |
| Total Share Holders Equity (after Deducting Minority Equity) | 1,553,966 | 1,522,525 | 2.065 |
| Profit (Loss) per Share | 0.39 | 1.36 | |
| All figures are in (Thousands) Saudi Arabia, Riyals |
| Element List | Explanation |
|---|---|
| Increase (Decrease) in Net Profit for Current Year Compared to Last Year is Attributed to | The decrease in net profit is due to stopping the capitalization of the costs of two production lines at one of the Company's subsidiaries (the Plant of AJA Pharmaceutical Industries Company Ltd.) as a result of commencing the commercial production and increase in the selling & marketing and general & administrative expenses. In addition to the increase in financing costs resulting from obtaining additional bank facilities and increase in the provisions for doubtful debts and zakat. |
| Basis of the External Auditor's Opinion | Unmodified opinion |
| Reclassification of Comparison Items | Certain figures of comparatives have been reclassified to conform to the presentation of the current year's financial statements. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.